Selected research
Industry Research
Ifosfamide Industry Research Report 2026
Market perspective
The global Ifosfamide market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Ifosfamide is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Ifosfamide is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Ifosfamide is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Ifosfamide include Taisheng Zhiyao, TEVA, Qilu Pharma, Mylan, Hengrui Medicine, Pfizer, Ruiying Pharma, Jinrui Pharma and Quanxing Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Ifosfamide market in terms of revenue (US$ million) and, where applicable, sales volume (kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Ifosfamide Market by Company
Taisheng Zhiyao
TEVA
Qilu Pharma
Mylan
Hengrui Medicine
Pfizer
Ruiying Pharma
Jinrui Pharma
Quanxing Pharma
Lingnan Pharma
Baxter
GLS Pharma
Ifosfamide Segment by Type
0.5g/Vial
1g/Vial
Ifosfamide Segment by Application
Retail Pharmacies
Online Pharmacies
Hospital Pharmacies
Ifosfamide Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ifosfamide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ifosfamide and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ifosfamide.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Ifosfamide manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Ifosfamide by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Ifosfamide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 0.5g/Vial
- 1g/Vial
Applications
- Retail Pharmacies
- Online Pharmacies
- Hospital Pharmacies
Companies covered
- Taisheng Zhiyao
- TEVA
- Qilu Pharma
- Mylan
- Hengrui Medicine
- Pfizer
- Ruiying Pharma
- Jinrui Pharma
- Quanxing Pharma
- Lingnan Pharma
- Baxter
- GLS Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Ifosfamide Market Size (2021-2032)
- 2.2.2 Global Ifosfamide Sales (2021-2032)
- 2.2.3 Global Ifosfamide Market Average Price (2021-2032)
- 2.3 Ifosfamide by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 0.5g/Vial
- 2.3.3 1g/Vial
- 2.4 Ifosfamide by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Retail Pharmacies
- 2.4.3 Online Pharmacies
- 2.4.4 Hospital Pharmacies
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Ifosfamide Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Ifosfamide Sales (kg) of Manufacturers (2021-2026)
- 3.3 Global Ifosfamide Revenue of Manufacturers (2021-2026)
- 3.4 Global Ifosfamide Average Price by Manufacturers (2021-2026)
- 3.5 Global Ifosfamide Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Ifosfamide, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Ifosfamide, Product Type & Application
- 3.8 Global Manufacturers of Ifosfamide, Established Date
- 3.9 Global Ifosfamide Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Taisheng Zhiyao
- 4.1.1 Taisheng Zhiyao Company Information
- 4.1.2 Taisheng Zhiyao Business Overview
- 4.1.3 Taisheng Zhiyao Ifosfamide Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Taisheng Zhiyao Ifosfamide Product Portfolio
- 4.1.5 Taisheng Zhiyao Recent Developments
- 4.2 TEVA
- 4.2.1 TEVA Company Information
- 4.2.2 TEVA Business Overview
- 4.2.3 TEVA Ifosfamide Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 TEVA Ifosfamide Product Portfolio
- 4.2.5 TEVA Recent Developments
- 4.3 Qilu Pharma
- 4.3.1 Qilu Pharma Company Information
- 4.3.2 Qilu Pharma Business Overview
- 4.3.3 Qilu Pharma Ifosfamide Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Qilu Pharma Ifosfamide Product Portfolio
- 4.3.5 Qilu Pharma Recent Developments
- 4.4 Mylan
- 4.4.1 Mylan Company Information
- 4.4.2 Mylan Business Overview
- 4.4.3 Mylan Ifosfamide Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Mylan Ifosfamide Product Portfolio
- 4.4.5 Mylan Recent Developments
- 4.5 Hengrui Medicine
- 4.5.1 Hengrui Medicine Company Information
- 4.5.2 Hengrui Medicine Business Overview
- 4.5.3 Hengrui Medicine Ifosfamide Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Hengrui Medicine Ifosfamide Product Portfolio
- 4.5.5 Hengrui Medicine Recent Developments
- 4.6 Pfizer
- 4.6.1 Pfizer Company Information
- 4.6.2 Pfizer Business Overview
- 4.6.3 Pfizer Ifosfamide Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Pfizer Ifosfamide Product Portfolio
- 4.6.5 Pfizer Recent Developments
- 4.7 Ruiying Pharma
- 4.7.1 Ruiying Pharma Company Information
- 4.7.2 Ruiying Pharma Business Overview
- 4.7.3 Ruiying Pharma Ifosfamide Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Ruiying Pharma Ifosfamide Product Portfolio
- 4.7.5 Ruiying Pharma Recent Developments
- 4.8 Jinrui Pharma
- 4.8.1 Jinrui Pharma Company Information
- 4.8.2 Jinrui Pharma Business Overview
- 4.8.3 Jinrui Pharma Ifosfamide Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Jinrui Pharma Ifosfamide Product Portfolio
- 4.8.5 Jinrui Pharma Recent Developments
- 4.9 Quanxing Pharma
- 4.9.1 Quanxing Pharma Company Information
- 4.9.2 Quanxing Pharma Business Overview
- 4.9.3 Quanxing Pharma Ifosfamide Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Quanxing Pharma Ifosfamide Product Portfolio
- 4.9.5 Quanxing Pharma Recent Developments
- 4.10 Lingnan Pharma
- 4.10.1 Lingnan Pharma Company Information
- 4.10.2 Lingnan Pharma Business Overview
- 4.10.3 Lingnan Pharma Ifosfamide Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Lingnan Pharma Ifosfamide Product Portfolio
- 4.10.5 Lingnan Pharma Recent Developments
- 4.11 Baxter
- 4.11.1 Baxter Company Information
- 4.11.2 Baxter Business Overview
- 4.11.3 Baxter Ifosfamide Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Baxter Ifosfamide Product Portfolio
- 4.11.5 Baxter Recent Developments
- 4.12 GLS Pharma
- 4.12.1 GLS Pharma Company Information
- 4.12.2 GLS Pharma Business Overview
- 4.12.3 GLS Pharma Ifosfamide Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 GLS Pharma Ifosfamide Product Portfolio
- 4.12.5 GLS Pharma Recent Developments
5 Global Ifosfamide Market Scenario by Region
- 5.1 Global Ifosfamide Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Ifosfamide Sales by Region: 2021-2032
- 5.2.1 Global Ifosfamide Sales by Region: 2021-2026
- 5.2.2 Global Ifosfamide Sales by Region: 2027-2032
- 5.3 Global Ifosfamide Revenue by Region: 2021-2032
- 5.3.1 Global Ifosfamide Revenue by Region: 2021-2026
- 5.3.2 Global Ifosfamide Revenue by Region: 2027-2032
- 5.4 North America Ifosfamide Market Facts & Figures by Country
- 5.4.1 North America Ifosfamide Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Ifosfamide Sales by Country (2021-2032)
- 5.4.3 North America Ifosfamide Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Ifosfamide Market Facts & Figures by Country
- 5.5.1 Europe Ifosfamide Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Ifosfamide Sales by Country (2021-2032)
- 5.5.3 Europe Ifosfamide Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Ifosfamide Market Facts & Figures by Country
- 5.6.1 Asia Pacific Ifosfamide Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Ifosfamide Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Ifosfamide Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Ifosfamide Market Facts & Figures by Country
- 5.7.1 South America Ifosfamide Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Ifosfamide Sales by Country (2021-2032)
- 5.7.3 South America Ifosfamide Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Ifosfamide Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Ifosfamide Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Ifosfamide Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Ifosfamide Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Ifosfamide Sales by Type (2021-2032)
- 6.1.1 Global Ifosfamide Sales by Type (2021-2032) & (kg)
- 6.1.2 Global Ifosfamide Sales Market Share by Type (2021-2032)
- 6.2 Global Ifosfamide Revenue by Type (2021-2032)
- 6.2.1 Global Ifosfamide Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Ifosfamide Revenue Market Share by Type (2021-2032)
- 6.3 Global Ifosfamide Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Ifosfamide Sales by Application (2021-2032)
- 7.1.1 Global Ifosfamide Sales by Application (2021-2032) & (kg)
- 7.1.2 Global Ifosfamide Sales Market Share by Application (2021-2032)
- 7.2 Global Ifosfamide Revenue by Application (2021-2032)
- 7.2.1 Global Ifosfamide Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Ifosfamide Revenue Market Share by Application (2021-2032)
- 7.3 Global Ifosfamide Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Ifosfamide Value Chain Analysis
- 8.1.1 Ifosfamide Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Ifosfamide Production Mode & Process
- 8.2 Ifosfamide Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Ifosfamide Distributors
- 8.2.3 Ifosfamide Customers
9 Global Ifosfamide Analyzing Market Dynamics
- 9.1 Ifosfamide Industry Trends
- 9.2 Ifosfamide Industry Drivers
- 9.3 Ifosfamide Industry Opportunities and Challenges
- 9.4 Ifosfamide Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst